A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Related Posts
Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]
Yang JC, Situ J, Troutman R, Zhu R, Black M, Buri H, Gutta A, Tian F, Kang A, Aja E, Zeng A, Lai RW, Tan[...]
Shree S, Pike M, Yee LM, Levine L, Simhan H, Silver RM, Greenland P, Saade G, Bairey Merz CN, Chung J, Cleary EM, Grobman W,[...]